← SynDRA
IBIPINABANT
SynDRA canonical compound SYN0008980 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CNR1 | DRD2 | HTR1A |
|---|
| Mechanism of action | cannabinoid receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- CNR1 ANTAGONIST
- Cannabinoid CB1 receptor antagonist
Drug classes
- Cannabinoid Receptor Antagonists
Cross-references
Synonyms
- Slv319
- BMS-646256
- SLV-319
- BMS 646256
- O5CSC6WH1T
- ibipinabantum
- RefChem:789638
- DTXCID501391318
- (S)-SLV 319
- C23H20Cl2N4O2S
- Ibipinabant [USAN]
- UNII-O5CSC6WH1T
- Ibipinabant [USAN:INN]
- JD 5001
- BMS 646256; SLV 319;JD 5001;Ibipinabant
- IBIPINABANT [INN]
- Ibipinabant (USAN/INN)
- IBIPINABANT [WHO-DD]
- SCHEMBL304252
- SCHEMBL304253
- SCHEMBL304254
- SCHEMBL675915
- GTPL9234
- orb1704925
- SCHEMBL1315224
- GLXC-01822
- HMS3650K08
- BDBM50230537
- EX-A10199
- MFCD07370146
- AKOS040744949
- (S)-(-)-SLV 319
- NCGC00386621-02
- HY-14791
- SLV-319-(+/-)
- CS-0003564
- NS00069679
- D09349
- E98949
Look up IBIPINABANT in the interactive SynDRA portal →